Infants and children are recommended to receive 4 doses of IPV-containing vaccine

Inactivated poliovirus (IPV)–containing vaccine is recommended for infants and children in a 4-dose schedule at 2, 4 and 6 months and 4 years of age.

Infants can have their 1st dose of IPV-containing vaccine as early as 6 weeks of age. If the 1st dose of IPV-containing vaccine is given at the age of 6 weeks, infants should still receive their next scheduled doses at 4 and 6 months of age.

The vaccines usually received at each schedule point are:

• 2, 4 and 6 months of age — DTPa-hepB-IPV-Hib (diphtheria-tetanus-acellular pertussis, hepatitis B, inactivated poliovirus, Haemophilus influenzae type b). There is no preferential recommendation between the use of DT5aP-hepB-IPV-Hib(PRP-OMP) vaccine (Vaxelis) and DT3aP-hepB-IPV-Hib(PRP-TT) vaccine (Infanrix hexa) 
• 4 years of age — DTPa-IPV (diphtheria-tetanus-acellular pertussis, inactivated poliovirus)

IPV containing vaccine is funded through the NIP for all infants and children. For details see the National Immunisation Program Schedule.